ChemoCentryx
CCXI
$51.99
Share price
0.00%
Change (1 day)
33.72%
Change (1 year)
Categories
Earnings for ChemoCentryx (CCXI)
Earnings in 2022 (TTM): -$0.14 B
According to ChemoCentryx's latest financial reports the company's current earnings (TTM) are -$0.14 B. In 2021 the company made an earning of -$0.13 B a decrease over its 2020 earnings that were of -$52.72 M.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for ChemoCentryx from 2011 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -$0.14 B | 1.19% |
| 2021 | -$0.13 B | 144.84% |
| 2020 | -$52.72 M | -1.18% |
| 2019 | -$53.34 M | 45.17% |
| 2018 | -$36.75 M | -305.69% |
| 2017 | $17.86 M | -144.7% |
| 2016 | -$39.97 M | -15.52% |
| 2015 | -$47.31 M | 0.85% |
| 2014 | -$46.91 M | 21.47% |
| 2013 | -$38.62 M | -1.24% |
| 2012 | -$39.1 M | 906.88% |
| 2011 | -$3.89 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $21.36 B | -16,457.58% | 🇺🇸 USA |
 Pfizer PFE | $3.26 B | -2,601.53% | 🇺🇸 USA |
 AbbVie ABBV | $6.25 B | -4,885.60% | 🇺🇸 USA |
 Amgen AMGN | $7.85 B | -6,114.55% | 🇺🇸 USA |
 Biogen BIIB | $1.32 B | -1,113.25% | 🇺🇸 USA |
 Merck MRK | $3.03 B | -2,423.89% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | 4,376.26% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $6.88 B | -5,371.91% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $0.40 B | -410.11% | 🇮🇱 Israel |